Critical Vertebroplasty Studies Raise Questions
By
Tom Salemi / Email the Author / IN VIVO September 2009, Vol. 27, No. 8
Around The Industry / Word Count: 1468 / Article # 2009800150
Executive Summary
The lines separating politics and the medical device industry have long been erased as industry, regulators and insurers wrangle over critical issues like innovation, product approval and compensation for medical care. But the New England Journal of Medicine tossed itself into the tangle last month by publishing two clinical trials that called into question the efficacy of vertebroplasty, the increasingly common procedure that involves the percutaneous injection of bone cement in the core of a fractured vertebra.
Already a Subscriber?
Log in for complete access.
Log In
Questions?
Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.